Rethinking risk in pediatric research.

This article reviews four areas of pediatric research in which we have identified questionable levels of allowable risk, exceeding those foreseen by the Commission. They are the following: (1) the categorization of increasingly risky interventions as minimal risk in a variety of protocols; (2) the i...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Glass, K, Binik, A
Μορφή: Journal article
Γλώσσα:English
Έκδοση: 2008
_version_ 1826278236535914496
author Glass, K
Binik, A
author_facet Glass, K
Binik, A
author_sort Glass, K
collection OXFORD
description This article reviews four areas of pediatric research in which we have identified questionable levels of allowable risk, exceeding those foreseen by the Commission. They are the following: (1) the categorization of increasingly risky interventions as minimal risk in a variety of protocols; (2) the increasing number of applications for federal panel review of research not otherwise approvable because of higher projected risk levels; (3) research on asymptomatic at risk children; and (4) the inclusion of children and adolescents in placebo-controlled trials for participants of all ages without performing subgroup analysis. While embracing the imperative to include children in research is an encouraging step towards providing the pediatric population with effective medical care and finally eradicating the therapeutic orphan, we must ensure that this research does not become overly permissive.
first_indexed 2024-03-06T23:40:56Z
format Journal article
id oxford-uuid:6f49c157-df14-4b17-85fb-a3e0a0ec23c1
institution University of Oxford
language English
last_indexed 2024-03-06T23:40:56Z
publishDate 2008
record_format dspace
spelling oxford-uuid:6f49c157-df14-4b17-85fb-a3e0a0ec23c12022-03-26T19:29:44ZRethinking risk in pediatric research.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6f49c157-df14-4b17-85fb-a3e0a0ec23c1EnglishSymplectic Elements at Oxford2008Glass, KBinik, AThis article reviews four areas of pediatric research in which we have identified questionable levels of allowable risk, exceeding those foreseen by the Commission. They are the following: (1) the categorization of increasingly risky interventions as minimal risk in a variety of protocols; (2) the increasing number of applications for federal panel review of research not otherwise approvable because of higher projected risk levels; (3) research on asymptomatic at risk children; and (4) the inclusion of children and adolescents in placebo-controlled trials for participants of all ages without performing subgroup analysis. While embracing the imperative to include children in research is an encouraging step towards providing the pediatric population with effective medical care and finally eradicating the therapeutic orphan, we must ensure that this research does not become overly permissive.
spellingShingle Glass, K
Binik, A
Rethinking risk in pediatric research.
title Rethinking risk in pediatric research.
title_full Rethinking risk in pediatric research.
title_fullStr Rethinking risk in pediatric research.
title_full_unstemmed Rethinking risk in pediatric research.
title_short Rethinking risk in pediatric research.
title_sort rethinking risk in pediatric research
work_keys_str_mv AT glassk rethinkingriskinpediatricresearch
AT binika rethinkingriskinpediatricresearch